These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 12644958

  • 21. Flumazenil in the treatment of portal systemic encephalopathy--an overview.
    Gyr K, Meier R.
    Intensive Care Med; 1991; 17 Suppl 1():S39-42. PubMed ID: 1774410
    [Abstract] [Full Text] [Related]

  • 22. The effect of flumazenil on subclinical psychometric or neurophysiological alterations in cirrhotic patients: a double-blind placebo-controlled study.
    Amodio P, Marchetti P, Del Piccolo F, Beghi A, Comacchio F, Carraro P, Campo G, Baruzzo L, Marchiori C, Gatta A.
    Clin Physiol; 1997 Sep; 17(5):533-9. PubMed ID: 9347201
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Flumazenil does not improve hepatic encephalopathy associated with acute ischemic liver failure in the rabbit.
    van der Rijt CC, de Knegt RJ, Schalm SW, Terpstra OT, Mechelse K.
    Metab Brain Dis; 1990 Sep; 5(3):131-41. PubMed ID: 2273999
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Evoked potentials and the effect of flumazenil in patients with liver cirrhosis.
    Ozyilkan E, Kahraman H, Onar M, Kesim G, Arik Z.
    East Afr Med J; 1997 Apr; 74(4):210-2. PubMed ID: 9299818
    [Abstract] [Full Text] [Related]

  • 28. [Benzodiazepine antagonists in the treatment of heptic encephalopathy].
    Ferenci P, Grimm G.
    Leber Magen Darm; 1989 Dec; 19(6):322-5. PubMed ID: 2575692
    [Abstract] [Full Text] [Related]

  • 29. Benzodiazepine receptor antagonist (flumazenil) does not affect sleep-related breathing disorders.
    Schönhofer B, Köhler D.
    Eur Respir J; 1996 Sep; 9(9):1816-20. PubMed ID: 8880096
    [Abstract] [Full Text] [Related]

  • 30. Improvement of hepatic encephalopathy treated with flumazenil.
    Grimm G, Ferenci P, Katzenschlager R, Madl C, Schneeweiss B, Laggner AN, Lenz K, Gangl A.
    Lancet; 1988 Dec 17; 2(8625):1392-4. PubMed ID: 2904525
    [Abstract] [Full Text] [Related]

  • 31. [Current possibilities in the therapy of hepatic encephalopathy].
    Meier PJ, Bansky G.
    Schweiz Med Wochenschr; 1990 Apr 14; 120(15):553-6. PubMed ID: 2159659
    [Abstract] [Full Text] [Related]

  • 32. [Flumazenil and hepatic failure].
    Larsen FS.
    Ugeskr Laeger; 2000 Nov 06; 162(45):6107. PubMed ID: 11107959
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Use of flumazenil in the treatment of drug overdose: a double-blind and open clinical study in 110 patients.
    Weinbroum A, Rudick V, Sorkine P, Nevo Y, Halpern P, Geller E, Niv D.
    Crit Care Med; 1996 Feb 06; 24(2):199-206. PubMed ID: 8605789
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat.
    Bosman DK, van den Buijs CA, de Haan JG, Maas MA, Chamuleau RA.
    Gastroenterology; 1991 Sep 06; 101(3):772-81. PubMed ID: 1650320
    [Abstract] [Full Text] [Related]

  • 40. Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil.
    Ferenci P, Grimm G, Meryn S, Gangl A.
    Gastroenterology; 1989 Jan 06; 96(1):240-3. PubMed ID: 2491822
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.